Novo Nordisk plans $1bn Brazil expansion ...Middle East

GCR - News
Novo Nordisk plans $1bn Brazil expansion
The Danish pharmaceutical company behind obesity drug Wegovy, Novo Nordisk, plans to invest US$1.09bn in expanding its facility in Minas Gerais, southeast Brazil.

The 74,000-sq-m project will be used for multiple products, including the GLP-1 hormone used in its diabetes treatment Ozempic.

Brazil is one of Novo Nordisk’s five biggest markets and the company exports to 70 countries from there, Reuters reports.

    Reinaldo Costa, corporate vice president of the Montes Claros facility said it would be a “considerable and significant increase”.

    The expanded factory is due to begin production in 2028.

    Novo Nordisk has played down concerns over US President Trump’s tariffs, noting it has factories in the US, plans for one of which were announced last June.

    Subscribe here to get stories about construction around the world in your inbox three times a week

    Further Reading:

    Wegovy-maker Novo Nordisk to build €390m quality control centre Novo Nordisk injects $4.1bn into latest US drug factory Anti-obesity drug maker to spend $6bn on new factories

    Novo Nordisk plans $1bn Brazil expansion Global Construction Review.

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Novo Nordisk plans $1bn Brazil expansion )

    Also on site :